Three cancer experts from the University of Maryland Greenebaum Cancer Center (UMGCC) participated in the second annual World Cancer Conference: Gateway to Future Medicine held in Beijing, China, June 22-25, 2009. The international conference focused on the latest advancements in cancer treatment and research and featured speakers from around the world to address current issues in cancer, from basic research to clinical therapy.
Nader N. Hanna, M.D., F.A.C.S., associate professor of surgery and chief of surgical oncology at UMGCC, chaired the session on pancreatic cancer and also gave a presentation entitled, "Pancreatic Cancer: Advances, Controversies and Evidence-based Multimodality Therapy."
Frank X. Zhao, M.D., Ph.D., assistant professor of pathology and director of the hematopathology laboratory, chaired the session on Non-Hodgkin's lymphoma and gave a presentation entitled: "Phospho-p70S6K and cdc2/cdk1 are Novel Molecular Targets for Diffuse Large B-cell Lymphoma Combination Therapy."
Amy M. Fulton, Ph.D., professor of pathology and a leader of the hormone responsive cancers research program at UMGCC, presented "Alternative Strategies to Target the COX-2 Pathway to Prevent Cancer Metastasis" during the Cancer/Tumor Invasion and Metastasis and Drug Discovery session.
The conference, sponsored by BIT Life Sciences, is intended as a platform to bring practicing oncologists and researchers together to exchange ideas, breakthroughs and promising solutions to the most challenging issues in their respective fields.